Sanofi (XPAR:SAN) Price-to-Operating-Cash-Flow

: 16.67 (As of Today)

View and export this data going back to 1999. Start your Free Trial

As of today (2024-04-24), Sanofi's share price is €88.85. Sanofi's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €5.33. Hence, Sanofi's Price-to-Operating-Cash-Flow Ratio for today is 16.67.

The historical rank and industry rank for Sanofi's Price-to-Operating-Cash-Flow or its related term are showing as below:

XPAR:SAN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.37 Med: 13.03 Max: 20.45
Current: 16.67

During the past 13 years, Sanofi's highest Price-to-Operating-Cash-Flow Ratio was 20.45. The lowest was 9.37. And the median was 13.03.

XPAR:SAN's Price-to-Operating-Cash-Flow is ranked better than
52.73% of 677 companies
in the Drug Manufacturers industry
Industry Median: 17.32 vs XPAR:SAN: 16.67

Sanofi's Cash Flow from Operations per share for the six months ended in Jun. 2023 was €0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €5.33.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Sanofi was -2.50% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 11.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 13.30% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 4.00% per year.

During the past 13 years, Sanofi's highest 3-Year average Operating Cash Flow per Share Growth Rate was 27.30% per year. The lowest was -13.20% per year. And the median was 8.50% per year.

Sanofi Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Sanofi's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

14.52

13.30

10.53

10.73

10.99

Sanofi Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															10.53	-	10.73	-	10.99

Competitive Comparison

For the Drug Manufacturers - General subindustry, Sanofi's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sanofi Price-to-Operating-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, Sanofi's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sanofi's Price-to-Operating-Cash-Flow falls into.

Sanofi Price-to-Operating-Cash-Flow Calculation

Sanofi's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	88.85	/	5.331
	=	16.67

Sanofi's Share Price of today is €88.85.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sanofi's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €5.33.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Sanofi Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Sanofi's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanofi (XPAR:SAN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (XPAR:SAN) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

SNYNF:USA SNY:USA SNY:Mexico SANF:Italy 0A2V:UK SANp:UK 0O59:UK SNW:Germany SNW2:Germany SNW:Germany SNW:Germany SNW2:Germany SNW:Germany SANO:Austria

Address

46, avenue de la Grande Armée, Paris, FRA, 75017

Website

https://www.sanofi.com

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 15% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.